PET imaging shows an uncommon case of thermal burns from repetitive ICD shocks: Case report Medha Baranwal26 May 2023 9:00 AM ISTUSA: A recent case study published in HeartRhythm Case Reports has described an uncommon case of thermal burn from multiple shocks resulting from...
Woman with diabetic foot ulcer and osteomyelitis successfully treated with ayurvedic treatment: case report Medha Baranwal25 May 2023 11:15 AM ISTRajasthan: Diabetic foot ulcer (DFU) with osteomyelitis is a devastating condition which frequently requires surgery to remove the infected and...
Aroxybutynin plus atomoxetine novel oral therapy for obstructive sleep apnea: MARIPOSA phase 2b trial Medha Baranwal25 May 2023 11:00 AM ISTUSA: The MARIPOSA Phase 2b trial, which sought to assess the safety, safety, and dosage requirements of AD109 (aroxybutynin + atomoxetine), an oral...
Dual-chamber leadless pacemaker shown to be safe and effective in Aveir DR i2i Study Medha Baranwal25 May 2023 10:30 AM ISTUSA: A dual-chamber leadless pacemaker system turned in very promising short-term results in patients with standard indications for dual-chamber...
DWI-MRI helpful for pre-operative evaluation of patients with ovarian cancer Medha Baranwal25 May 2023 9:30 AM ISTChina: A recent study published in Gynecologic Oncology has shown that diffusion-weighted MRI (DWI-MRI) is a good technique for selecting ovarian...
Abrocitinib effective treatment option for lichen sclerosus Medha Baranwal25 May 2023 9:15 AM ISTChina: Abrocitinib may provide disease control in Lichen sclerosus (LS) patients; however, more extensive controlled trials are required for results...
Inhaled nitrous oxide beneficial for IV insertions and laceration repair in children and youth Medha Baranwal25 May 2023 8:45 AM ISTCanada: A meta-analysis has shown that nitrous oxide (N2O) is beneficial for laceration repair and intravenous (IV) insertion in children as young as...
Oral diabetes drug Danuglipron achieves similar weight loss as Ozempic injection: JAMA Medha Baranwal24 May 2023 11:15 AM ISTUSA: Danuglipron demonstrated a safety and efficacy profile in tune with peptidic glucagon-like peptide 1 receptor agonists in type 2 diabetes (T2D)...
SGLT2 inhibitors used less frequently in HFrEF patients despite potential CV benefits: JAMA Medha Baranwal24 May 2023 10:30 AM ISTUSA: A recent study published in JAMA Cardiology found low rates of SGLT2 inhibitors for HFrEF (heart failure with reduced ejection fraction) in the...
Rare case of diabetic nephropathy with marked extra-capillary cell proliferation- A report Medha Baranwal23 May 2023 8:00 PM ISTJapan: A recent case study published in BMC Nephrology describes the rare case of finding extra-capillary hypercellularity in a patient with diabetic...
First-line bevacizumab treatment cost-effective for CRVO or HRVO-associated macular oedema: JAMA Medha Baranwal23 May 2023 10:30 AM ISTUSA: First-line treatment with bevacizumab of macular oedema associated with central or hemiretinal vein occlusion was cost-effective in a new...
Ropeg superior to phlebotomy alone in maintaining hematocrit control in polycythemia vera Medha Baranwal23 May 2023 9:30 AM ISTItaly: Exposure to low-dose ropeginterferon alfa-2b (ropeg) is more effective than the standard treatment of phlebotomy and aspirin in patients with...
